BLACK DIAMOND THERAPEUTICS, INC. Shares Outstanding (Cover Page)
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) had Shares Outstanding (Cover Page) of 57.45 million shares as of 2026-07-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-30: Entity Common Stock, Shares Outstanding 57.45M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 57.30M shares.
- 2026-03-11: Entity Common Stock, Shares Outstanding 57.29M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 56.97M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 57.45M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 57.30M shares 10-Q · filed 2026-05-07 |
| 2026-03-11 | 57.29M shares 10-K · filed 2026-03-16 |
| 2025-10-30 | 56.97M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 56.94M shares 10-Q · filed 2025-08-07 |
| 2025-05-06 | 56.86M shares 10-Q · filed 2025-05-12 |
| 2025-02-28 | 56.66M shares 10-K · filed 2025-03-06 |
| 2024-10-31 | 56.59M shares 10-Q · filed 2024-11-05 |
| 2024-08-01 | 56.50M shares 10-Q · filed 2024-08-06 |
| 2024-05-06 | 56.25M shares 10-Q · filed 2024-05-09 |
| 2024-03-05 | 51.72M shares 10-K · filed 2024-03-12 |
| 2023-10-30 | 51.64M shares 10-Q · filed 2023-11-06 |
| 2023-08-01 | 51.58M shares 10-Q · filed 2023-08-11 |
| 2023-05-01 | 36.51M shares 10-Q · filed 2023-05-09 |
| 2023-02-24 | 36.48M shares 10-K · filed 2023-03-09 |
| 2022-10-31 | 36.37M shares 10-Q · filed 2022-11-08 |
| 2022-07-28 | 36.34M shares 10-Q · filed 2022-08-09 |
| 2022-05-02 | 36.29M shares 10-Q · filed 2022-05-11 |
| 2022-02-28 | 36.27M shares 10-K · filed 2022-03-17 |
| 2021-11-01 | 36.23M shares 10-Q · filed 2021-11-08 |
| 2021-08-06 | 36.21M shares 10-Q · filed 2021-08-12 |
| 2021-04-27 | 36.16M shares 10-Q · filed 2021-05-07 |
| 2021-03-15 | 36.14M shares 10-K · filed 2021-03-25 |
| 2020-11-02 | 36.00M shares 10-Q · filed 2020-11-10 |
| 2020-08-05 | 35.91M shares 10-Q · filed 2020-08-11 |
| 2020-05-05 | 35.91M shares 10-Q · filed 2020-05-12 |
| 2020-03-16 | 35.91M shares 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |